Association of Shunt Size and Long-Term Clinical Outcomes in Patients with Cryptogenic Ischemic Stroke and Patent Foramen Ovale on Medical Management

• Published in: Journal of clinical medicine Vol. 12; no. 3; p. 941
• Main Authors: Lim, Isis Claire Z Y, Teo, Yao Hao, Fang, Jun Tao, Teo, Yao Neng, Ho, Jamie S Y, Lee, Yong Qin, Chen, Xintong, Ong, Kathleen Hui-Xin, Leow, Aloysius S T, Ho, Andrew Fu-Wah, Lim, Yinghao, Low, Ting Ting, Kuntjoro, Ivandito, Yeo, Leonard L L, Sia, Ching-Hui, Sharma, Vijay K, Tan, Benjamin Y Q
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.01.2023; MDPI
• Subjects: Antibodies; Clinical medicine; Clinical outcomes; Cohort analysis; cryptogenic stroke; Embolisms; Glycoproteins; Mortality; patent foramen ovale; PFO closure; Regression analysis; shunt size; Stroke; Transient ischemic attack; Ultrasonic imaging; patent foramen ovale; PFO closure; cryptogenic stroke; shunt size
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12030941

Patent foramen ovale (PFO) is a potential source of cardiac embolism in cryptogenic ischemic stroke, but it may also be incidental. Right-to-left shunt (RLS) size may predict PFO-related stroke, but results have been controversial. In this cohort study of medically-managed PFO patients with cryptogenic stroke, we aimed to investigate the association of shunt size with recurrent stroke, mortality, newly detected atrial fibrillation (AF), and to identify predictors of recurrent stroke. Patients with cryptogenic stroke who screened positive for a RLS using a transcranial Doppler bubble study were included. Patients who underwent PFO closure were excluded. Subjects were divided into two groups: small (Spencer Grade 1, 2, or 3; = 135) and large (Spencer Grade 4 or 5; = 99) shunts. The primary outcome was risk of recurrent stroke, and the secondary outcomes were all-cause mortality and newly detected AF. The study cohort included 234 cryptogenic stroke patients with medically-managed PFO. The mean age was 50.5 years, and 31.2% were female. The median period of follow-up was 348 (IQR 147-1096) days. The rate of recurrent ischemic stroke was higher in patients with large shunts than in those with small shunts (8.1% vs. 2.2%, = 0.036). Multivariate analyses revealed that a large shunt was significantly associated with an increased risk of recurrent ischemic stroke [aOR 4.09 (95% CI 1.04-16.0), = 0.043]. In our cohort of cryptogenic stroke patients with medically managed PFOs, those with large shunts were at a higher risk of recurrent stroke events, independently of RoPE score and left atrium diameter.